Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia
This is a small phase I study examining the safety and efficacy of a cladribine (CLAD)-containing conditioning regimen prior to autologous hematopoietic stem cell transplantion (auto-HSCT) for patients with acute myeloid leukemia (AML). All patients, aged 15-54 years (median 32 years), had favorable...
Saved in:
Main Authors: | Yuan-Yuan Shi (Author), Zeng-Yan Liu (Author), Gui-Xin Zhang (Author), Yi He (Author), Ming-Zhe Han (Author), Si-Zhou Feng (Author), Rong-Li Zhang (Author), Er-Lie Jiang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and toxicity of cladribine for the treatment of refractory acute myeloid leukemia: a meta-analysis
by: Zhou A, et al.
Published: (2019) -
Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
by: Yuan J, et al.
Published: (2021) -
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
by: Ibrahim El‐Serafi, et al.
Published: (2020) -
Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
by: Romeo-Gabriel Mihaila
Published: (2015) -
Berberine protects cyclophosphamide and busulfan-induced premature ovarian insufficiency in mouse model
by: Ying Peng, et al.
Published: (2023)